Holen Sie sich die Stockscreener-App
0.23
3.56%
-0.0085
Handel nachbörslich:
.23
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MRNS?
Forum
Prognose
Aktiensplit
Finanzdaten der Marinus Pharmaceuticals Inc-Aktie (MRNS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
6.80%
7.679
|
7.19 | 7.338 | 6.081 | 10.38 |
Operating Expenses
|
2.05%
43.50
|
42.63 | 38.98 | 37.52 | 43.34 |
| Interest Income/Expense |
1.12%
4.346
|
4.298 | 4.242 | 4.208 | 4.147 |
| Benefits Costs and Expenses |
5.33%
46.35
|
48.96 | 40.31 | 39.55 | 45.11 |
| Costs And Expenses |
2.05%
43.50
|
42.63 | 38.98 | 37.52 | 43.34 |
| Operating Income/Loss |
1.08%
-35.82
|
-35.44 | -31.65 | -31.44 | -32.96 |
| Income/Loss From Continuing Operations Before Tax |
7.42%
-38.67
|
-41.77 | -32.97 | -33.47 | -34.73 |
| Income/Loss From Continuing Operations After Tax |
7.42%
-38.67
|
-41.77 | -32.97 | -31.93 | -34.73 |
|
Net Income/Loss
|
7.42%
-38.67
|
-41.77 | -32.97 | -31.93 | -34.73 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
5,634%
56.85
|
0.9914 | 53.92 | 52.55 | 51.77 |
| Diluted Average Shares |
5,634%
56.85
|
0.9914 | 53.92 | 52.55 | 51.77 |
| Basic Earnings Per Share |
8.11%
-0.68
|
-0.74 | -0.61 | -0.61 | -0.67 |
| Diluted Earnings Per Share |
8.11%
-0.68
|
-0.74 | -0.61 | -0.61 | -0.67 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):